2nd Quarter - Report

NOSSAMAN LLP for AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP")

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H.R.1392 and S.1221, legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price.

LobbyistCovered position, as disclosed
TIMOTHY W JENKINS —
SHERRY HARPER WIDICUS Legislative Director, Congressman Ron Kind

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1221 (111th), H.R. 1392 (111th)

Pharmacy PHA

H.R.1392 and S.1221, legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price.

LobbyistCovered position, as disclosed
TIMOTHY W JENKINS —
SHERRY HARPER WIDICUS Legislative Director, Congressman Ron Kind

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1392 (111th), S. 1221 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.